Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Testing different ICA algorithms and connectivity analyses on MS patients.
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series.
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Development and validation of the Dutch version of the London Handicap Scale.
A JOINT FRAMEWORK FOR 4D SEGMENTATION AND ESTIMATION OF SMOOTH TEMPORAL APPEARANCE CHANGES.
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Cerebrospinal fluid proteomics in multiple sclerosis.
Neuroplasticity and motor rehabilitation in multiple sclerosis.
Hormonal and gender-related immune changes in multiple sclerosis.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Spatial tuning function of pattern visual evoked potentials in multiple sclerosis patients without optic neuritis history.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]
Diagnostic criteria for pediatric multiple sclerosis.
Temporally Consistent Probabilistic Detection of New Multiple Sclerosis Lesions in Brain MRI.
Trigeminal neuralgia: A new therapy?
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
PML after natalizumab discontinuation: Few and true?
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Evaluation of Muscle Performance and Cardiopulmonary Fitness in Patients with Multiple SclerosisImplications for Rehabilitation.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Pages
« first
‹ previous
…
542
543
544
545
546
547
548
549
550
…
next ›
last »